Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,232 public trials 1,022 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer

NCT00741988

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Gainsville Hematology Oncology Associates Gainesville, Florida, United States
  • Providence Medical Group Terre Haute, Indiana, United States
  • Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States
View all 13 locations
View Trial Details
Completed

PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers

NCT02936323

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +18 more
Locations
  • Florida Cancer Specialists South Fort Myers, Florida, United States
  • Florida Cancer Specialists North St. Petersburg, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Boston Medical Center Boston, Massachusetts, United States
View all 13 locations
View Trial Details
Completed

A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies

NCT00730639

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +34 more
Locations
  • Pinnacle Oncology Hematology Scottsdale, Arizona, United States
  • Yale University School Of Medicine New Haven, Connecticut, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 13 locations
View Trial Details
Completed

Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung Cancer

NCT00695292

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Florida Hospital Cancer Insitute Orlando, Florida, United States
  • Northeast Georgia Medical Center Gainesville, Georgia, United States
  • Baton Rouge General Medical Center Baton Rouge, Louisiana, United States
View Trial Details
Completed

FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors

NCT03319459

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +63 more
Locations
  • UCSD Moores Cancer Center San Diego, California, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • The Ohio State University James Cancer Hospital Columbus, Ohio, United States
  • Baylor Scott & White Research Institute Dallas, Texas, United States
View Trial Details

Related conditions